Commentary on “Common Genetic Polymorphisms Modify the Effect of Smoking on Absolute Risk of Bladder Cancer.” Garcia-Closas M, Rothman N, Figueroa JD, Prokunina-Olsson L, Han SS, Baris D, Jacobs EJ, Malats N, De Vivo I, Albanes D, Purdue MP, Sharma S, Fu YP, Kogevinas M, Wang Z, Tang W, Tardón A, Serra C, Carrato A, García-Closas R, Lloreta J, Johnson A, Schwenn M, Karagas MR, Schned A, Andriole G Jr., Grubb R 3rd, Black A, Gapstur SM, Thun M, Diver WR, Weinstein SJ, Virtamo J, Hunter DJ, Caporaso N, Landi MT, Hutchinson A, Burdett L, Jacobs KB, Yeager M, Fraumeni JF Jr., Chanock SJ, Silverman DT, Chatterjee N, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.: Cancer Res 2013;73(7):2211–20 [Epub 2013 Mar 27]

Autor: Scherr, Douglas S.

Publikováno v: In Urologic Oncology: Seminars and Original Investigations February 2014 32(2):213-214

Genome-wide Association Study of Bladder Cancer Reveals New Biological and Translational Insights

Autor: Koutros, S., Kiemeney, L.A., Pal Choudhury, P., Milne, R.L., Lopez de Maturana, E., Ye, Y., Joseph, V., Florez-Vargas, O., Dyrskjøt, L., Figueroa, J., Dutta, D., Giles, G.G., Hildebrandt, M.A.T., Offit, K., Kogevinas, M., Weiderpass, E., McCullough, M.L., Freedman, N.D., Albanes, D., Kooperberg, C., Cortessis, V.K., Karagas, M.R., Johnson, A., Schwenn, M.R., Baris, D., Furberg, H., Bajorin, D.F., Cussenot, O., Cancel-Tassin, G., Benhamou, S., Kraft, P., Porru, S., Carta, A., Bishop, T., Southey, M.C., Matullo, G., Fletcher, T., Kumar, R., Taylor, J.A., Lamy, P., Prip, F., Kalisz, M., Weinstein, S.J., Hengstler, J.G., Selinski, S., Harland, M., Teo, M., Kiltie, A.E., Tardón, A., Serra, C., Carrato, A., García-Closas, R., Lloreta, J., Schned, A., Lenz, P., Riboli, E., Brennan, P., Tjønneland, A., Otto, T., Ovsiannikov, D., Volkert, F., Vermeulen, S.H., Aben, K.K.H., Galesloot, T.E., Turman, C., Vivo, I. De, Giovannucci, E., Hunter, D.J., Hohensee, C., Hunt, R., Patel, A.V., Huang, W.Y., Thorleifsson, G., Gago-Dominguez, M., Amiano, P., Golka, K., Stern, M.C., Yan, W., Liu, J., Li, S.A., Katta, S., Hutchinson, A., Hicks, B., Wheeler, W.A., Purdue, M.P., McGlynn, K.A., Kitahara, C.M., Haiman, C.A., Greene, M.H., Rafnar, T., Chatterjee, N., Chanock, S.J., Wu, X., Real, F.X., Silverman, D.T., Garcia-Closas, M., Stefansson, K., Prokunina-Olsson, L., Malats, N., Rothman, N.

Publikováno v: European Urology, 84, 127-137

BACKGROUND: Genomic regions identified by genome-wide association studies (GWAS) for bladder cancer risk provide new insights into etiology. OBJECTIVE: To identify new susceptibility variants for bladder cancer in a meta-analysis of new and existing

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::826091046a4f4a5d609222ea0dd86e25
http://hdl.handle.net/2066/293880

Occupation and bladder cancer in a hospital-based case—control study in Spain

Autor: Samanic, C M, Kogevinas, M, Silverman, D T, Tardón, A, Serra, C, Malats, N, Real, F X, Carrato, A, García-Closas, R, Sala, M, Lloreta, J, Rothman, N, Dosemeci, M

Publikováno v: Occupational and Environmental Medicine, 2008 May 01. 65(5), 347-353.

Externí odkaz: https://www.jstor.org/stable/25835209

Genome-wide Association Study of Bladder Cancer Reveals New Biological and Translational Insights.

Autor: Koutros S; Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA. Electronic address: koutross@mail.nih.gov., Kiemeney LA; Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands., Pal Choudhury P; Trans-Divisional Research Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA; American Cancer Society, Atlanta, GA, USA., Milne RL; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Australia; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Australia., Lopez de Maturana E; Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Centre (CNIO) and CIBERONC, Madrid, Spain., Ye Y; Zhejiang University, Hangzhou, China., Joseph V; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Florez-Vargas O; Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Dyrskjøt L; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Figueroa J; Usher Institute, University of Edinburgh, Edinburgh, UK; Integrative Tumor Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Dutta D; Integrative Tumor Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Giles GG; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Australia; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Australia., Hildebrandt MAT; University of Texas MD Anderson Cancer Center, Houston, TX, USA., Offit K; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Kogevinas M; Instituto de Salud Global, Barcelona, Spain., Weiderpass E; International Agency for Research on Cancer, Lyon, France., McCullough ML; Population Science, American Cancer Society, Atlanta, GA, USA., Freedman ND; Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Albanes D; Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Kooperberg C; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA, USA., Cortessis VK; Department of Population and Public Health Sciences, Epidemiology and Genetics, University of Southern California, Los Angeles, CA, USA., Karagas MR; Department of Epidemiology, Geisel School of Medicine at Dartmouth, Hanover, NH, USA., Johnson A; Vermont Department of Health, Burlington, VT, USA., Schwenn MR; Retired, Maine Cancer Registry, Augusta, ME, USA., Baris D; Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Furberg H; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Bajorin DF; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Cussenot O; Centre de Recherche sur les Pathologies Prostatiques et Urologiques, Paris, France., Cancel-Tassin G; Centre de Recherche sur les Pathologies Prostatiques et Urologiques, Paris, France; GRC 5 Predictive Onco-Urology, Sorbonne University, Paris, France., Benhamou S; INSERM U1018, Research Centre on Epidemiology and Population Health, Villejuif, France., Kraft P; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA., Porru S; Department of Diagnostics and Public Health, Section of Occupational Medicine, University of Verona, Verona, Italy., Carta A; Department of Diagnostics and Public Health, Section of Occupational Medicine, University of Verona, Verona, Italy., Bishop T; Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK., Southey MC; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Australia; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Australia; Department of Clinical Pathology, The University of Melbourne, Parkville, Australia., Matullo G; Department of Medical Sciences, University of Turin, Turin, Italy., Fletcher T; London School of Hygiene and Tropical Medicine, London, UK., Kumar R; Division of Functional Genome Analysis, German Cancer Research Center, Heidelberg, Germany., Taylor JA; Epidemiology Branch and Epigenetic and Stem Cell Biology Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC, USA., Lamy P; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark., Prip F; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark., Kalisz M; Epithelial Carcinogenesis Group, Spanish National Cancer Research Centre (CNIO) and CIBERONC, Madrid, Spain., Weinstein SJ; Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Hengstler JG; Leibniz Research Centre for Working Environment and Human Factors at TU Dortmund (IfADo), Dortmund, Germany., Selinski S; Leibniz Research Centre for Working Environment and Human Factors at TU Dortmund (IfADo), Dortmund, Germany., Harland M; Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK., Teo M; Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK., Kiltie AE; Rowett Institute, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, UK., Tardón A; Department of Preventive Medicine, Universidad de Oviedo, ISPA and CIBERESP, Spain., Serra C; Center for Research in Occupational Health, Universitat Pompeu Fabra, Hospital del Mar Medical Research Institut, CIBERESP, Barcelona, Spain., Carrato A; Department of Medicine, Alcalá University, IRYCIS, CIBERONC, Madrid, Spain., García-Closas R; Hospital Universitario de Canarias, Tenerife, Spain., Lloreta J; Hospital del Mar, Universitat Pompeu Fabra, Barcelona, Spain., Schned A; Department of Pathology, Dartmouth Medical School, Hanover, NH, USA., Lenz P; Cancer Genomics Research Laboratory, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Riboli E; School of Public Health, Imperial College London, London, UK., Brennan P; International Agency for Research on Cancer, Lyon, France., Tjønneland A; Danish Cancer Society Research Center, Copenhagen, Denmark., Otto T; Department of Urology, Rheinland Klinikum, Lukaskrankenhaus, Neuss, Germany., Ovsiannikov D; Department of Urology, St.-Josefs-Hospital, Dortmund, Germany., Volkert F; Department of Urology, Evangelic Hospital, Paul Gerhardt Foundation, Lutherstadt Wittenberg, Germany., Vermeulen SH; Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands., Aben KK; Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands; Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands., Galesloot TE; Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands., Turman C; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA., De Vivo I; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA; Department of Medicine, Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Giovannucci E; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA., Hunter DJ; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA; Nuffield Department of Population Health, University of Oxford, Oxford, UK., Hohensee C; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA, USA., Hunt R; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA, USA., Patel AV; Population Science, American Cancer Society, Atlanta, GA, USA., Huang WY; Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Thorleifsson G; deCODE genetics/Amgen, Reykjavik, Iceland., Gago-Dominguez M; Fundación Pública Galega de Medicina Xenómica, Servicio Galego de Saude, Health Research Institute of Santiago de Compostela, Santiago de Compostela, Spain., Amiano P; Ministry of Health of the Basque Government, Sub Directorate for Public Health and Addictions of Gipuzkoa, San Sebastian, Spain; Biodonostia Health Research Institute, Epidemiology of Chronic and Communicable Diseases Group, San Sebastian, Spain; Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain., Golka K; Leibniz Research Centre for Working Environment and Human Factors at TU Dortmund (IfADo), Dortmund, Germany., Stern MC; Department of Population and Public Health Sciences, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA., Yan W; Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Liu J; Cancer Genomics Research Laboratory, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Li SA; Cancer Genomics Research Laboratory, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Katta S; Cancer Genomics Research Laboratory, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Hutchinson A; Cancer Genomics Research Laboratory, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Hicks B; Cancer Genomics Research Laboratory, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Wheeler WA; Information Management Services, Inc, Rockville, MD, USA., Purdue MP; Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., McGlynn KA; Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Kitahara CM; Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Haiman CA; Center for Genetic Epidemiology, Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA., Greene MH; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Rafnar T; deCODE genetics/Amgen, Reykjavik, Iceland., Chatterjee N; Johns Hopkins University, Baltimore, MD, USA., Chanock SJ; Office of the Director, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Wu X; Zhejiang University, Hangzhou, China., Real FX; Epithelial Carcinogenesis Group, Spanish National Cancer Research Centre (CNIO) and CIBERONC, Madrid, Spain; Departament de Medicina i Ciències de la Vida, Universitat Pompeu Fabra, Barcelona, Spain., Silverman DT; Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Garcia-Closas M; Trans-Divisional Research Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Stefansson K; deCODE genetics/Amgen, Reykjavik, Iceland., Prokunina-Olsson L; Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Malats N; Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Centre (CNIO) and CIBERONC, Madrid, Spain., Rothman N; Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.

Publikováno v: European urology [Eur Urol] 2023 Jul; Vol. 84 (1), pp. 127-137. Date of Electronic Publication: 2023 May 19.

Gender-Related Differences in Clinical and Pathological Characteristics and Therapy of Bladder Cancer

Autor: Puente, D, Malats, N, Cecchini, L, Tardón, A, Garcı́a-Closas, R, Serra, C, Carrato, A, Sala, M, Boixeda, R, Dosemeci, M, Real, F.X, Kogevinas, M

Publikováno v: In European Urology 2003 43(1):53-62